扫描下面的二维码:
"现场快报"标签列表
INHERITED VARIANTS OF GENES INVOLVED IN INSULIN SIGNALING AND LIPOGENESIS INFLUENCE THE RISK OF (3)2007-11-14
INHERITED VARIANTS OF GENES INVOLVED IN INSULIN SIGNALING AND LIPOGENESIS INFLUENCE THE RISK OF (4)2007-11-14
INHERITED VARIANTS OF GENES INVOLVED IN INSULIN SIGNALING AND LIPOGENESIS INFLUENCE THE RISK OF (1)2007-11-14
INHERITED VARIANTS OF GENES INVOLVED IN INSULIN SIGNALING AND LIPOGENESIS INFLUENCE THE RISK OF (2)2007-11-14
Relationship of BMI, Metabolic Syndrome and NASH in Adults(4)2007-11-14
Relationship of BMI, Metabolic Syndrome and NASH in Adults(2)2007-11-14
Relationship of BMI, Metabolic Syndrome and NASH in Adults(3)2007-11-14
Relationship of BMI, Metabolic Syndrome and NASH in Adults(1)2007-11-14
TRB3 IS ASSOCIATED WITH HEPATIC LIPOGENESIS AND DYSLIPIDEMIA IN(4)2007-11-14
TRB3 IS ASSOCIATED WITH HEPATIC LIPOGENESIS AND DYSLIPIDEMIA IN(2)2007-11-14
TRB3 IS ASSOCIATED WITH HEPATIC LIPOGENESIS AND DYSLIPIDEMIA IN(3)2007-11-14
TRB3 IS ASSOCIATED WITH HEPATIC LIPOGENESIS AND DYSLIPIDEMIA IN(1)2007-11-14
Prevention of Hepatic Fibrosis in a Murine Model of Metabolic Syndrome with Non-Alcoholic(4)2007-11-14
Prevention of Hepatic Fibrosis in a Murine Model of Metabolic Syndrome with Non-Alcoholic(3)2007-11-14
Prevention of Hepatic Fibrosis in a Murine Model of Metabolic Syndrome with Non-Alcoholic(1)2007-11-14
Prevention of Hepatic Fibrosis in a Murine Model of Metabolic Syndrome with Non-Alcoholic(2)2007-11-14
Novel Therapeutic Approach for Nonalcoholic Fatty Liver Disease (NAFLD) using Antiplatelet (5)2007-11-14
Novel Therapeutic Approach for Nonalcoholic Fatty Liver Disease (NAFLD) using Antiplatelet (4)2007-11-14
Novel Therapeutic Approach for Nonalcoholic Fatty Liver Disease (NAFLD) using Antiplatelet (3)2007-11-14
Novel Therapeutic Approach for Nonalcoholic Fatty Liver Disease (NAFLD) using Antiplatelet (2)2007-11-14